New to The Street Broadcasts Tonight Featuring BioVie, Acurx, Lantern Pharma, SafeSpace Global

New to The Street, a leading financial and business media platform, is set to air a special broadcast tonight at 6:30 PM Eastern Time. The program, which will be shown across Bloomberg Television's U.S., Latin America, and Middle East and North Africa markets, will feature executives from BioVie Inc., Acurx Pharmaceuticals Inc., Lantern Pharma Inc., and SafeSpace Global.

Tonight’s broadcast will bring together four companies addressing significant global challenges, including Long COVID and antibiotic resistance, cancer treatment, and public safety. The program is part of New to The Street's ongoing efforts to provide direct communication to investors, industry leaders, and the public.

BioVie Inc., a clinical-stage biopharmaceutical company, will be represented by its President and CEO, Cuong Do. Do will discuss the company's recently announced Phase 2 ADDRESS-LC results, which evaluated bezisterim in patients suffering from Long COVID. The results showed encouraging signals across multiple clinical endpoints, including areas related to fatigue, post-exertional malaise, and cognitive symptoms. Do will also discuss the potential implications of these results for the continued clinical development of bezisterim, the design of a potential Phase 3 program, and the millions of patients still in need of an effective Long COVID treatment.

Acurx Pharmaceuticals Inc. will be represented by its CEO, David Luci. Luci will present the company's work developing a new class of antibiotics for difficult-to-treat bacterial infections. The company's lead product candidate, ibezapolstat, is being developed as a potential treatment for Clostridioides difficile infection, commonly known as C. difficile or C. diff. The interview will explore the company's recent scientific developments, global intellectual-property portfolio, and plans for advancing ibezapolstat toward Phase 3 clinical development.

Lantern Pharma Inc., applying artificial intelligence, machine learning, and biomarker-driven drug development to transform the economics and timeline of oncology research, will be represented by its CEO, Panna Sharma. Sharma will discuss how the company's proprietary RADR® artificial-intelligence platform is designed to help identify patient populations, uncover new therapeutic indications, and accelerate the development of precision oncology drug candidates.

SafeSpace Global, CEO Scott Boruff, will present its artificial intelligence-powered security platform, designed to improve threat detection, emergency response, and situational awareness across schools, senior-care facilities, and other vulnerable environments. The interview will explore how SafeSpace Global combines advanced technology with real-world security applications to help organizations identify risks earlier, coordinate responses faster, and create safer spaces for the communities they serve.

Founded in 2009, New to The Street is a leading financial and business media platform producing sponsored programming, executive interviews, digital content, and outdoor advertising campaigns for public and private companies. The platform broadcasts weekly across the United States, Latin America, the Middle East and North Africa, and Southeast Asia. Its expanding media ecosystem combines international television distribution, more than 6.3 million YouTube subscribers across New to The Street TV and NewsOut, social-media amplification, earned-media distribution, and high-impact billboard exposure throughout New York City's Times Square.